AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Merovista-DT EDTA Injection

Prescription Icon
Prescription Required

Marketer

Alvista Biosciences Pvt Ltd

Salt Composition

Meropenem (1000mg)

Overview Merovista-DT EDTA Injection

Administered intravenously, InfectiCare-EDTA combats severe bacterial infections affecting vital organs, including the skin, lungs, gastrointestinal tract, urinary system, bloodstream, and brain (e.g., meningitis). Its bactericidal action targets the causative pathogens. Importantly, it's ineffective against viral infections. Primarily indicated for critically ill hospitalized patients, InfectiCare-EDTA is delivered via infusion or direct injection under strict medical supervision. Dosage is individualized based on infection type, location, and severity. Continuous administration, as prescribed, is crucial; premature cessation risks relapse or exacerbation. Potential adverse effects, such as headache, nausea, bowel irregularities, anemia, vomiting, and skin rashes, are typically transient. Persistent or bothersome side effects warrant immediate medical attention. Pre-treatment disclosure of epilepsy, hepatic or renal impairment, or antibiotic allergies is mandatory. Regular blood tests to monitor hematologic parameters and renal function may be recommended during therapy. Generally considered safe during pregnancy and lactation under physician guidance.

Uses of Merovista-DT EDTA Injection

Life-threatening bacterial infections

Major Benefits of Merovista-DT EDTA Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Merovista-DT EDTA Injection:

  • Rash
  • Headache
  • Vomiting
  • Nausea
  • Itching
  • Diarrhea
  • Injection site inflammation
  • Anemia (low number of red blood cells)
  • Sepsis
  • Constipation
  • Apnea (absence of breathing)
  • Shock

How to use Merovista-DT EDTA Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Merovista-DT EDTA Injection works:

Merovista-DT EDTA Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, thereby eliminating the bacteria's protective barrier and causing its death.

SAFETY ADVICE

AlcoholAlcoholSAFE

Merovista-DT EDTA Injection's concurrent use with alcohol presents no known adverse reactions.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Merovista-DT EDTA Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, data from human studies are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administration of Merovista-DT EDTA Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Merovista-DT EDTA Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Individuals with impaired kidney function should exercise caution when using Merovista-DT EDTA Injection. The prescribed dosage of Merovista-DT EDTA Injection might require modification. A physician's consultation is advised.

LiverLiverSAFE IF PRESCRIBED

Merovista-DT EDTA Injection poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.

What if you forget to take Merovista-DT EDTA Injection :

Omitting a scheduled dose of Merovista-DT EDTA Injection warrants contacting your physician.

Facts to Know About Merovista-DT EDTA Injection

LabelValue
Type of Compound Carbapenem-based antibiotic
Potential for Dependence None.
Treatment Category Agents against infection
Mechanism of Action Carbapenems: Inhibitors of bacterial cell wall synthesis.

FAQs on Merovista-DT EDTA Injection

Prior medication use should be disclosed to your physician before commencing Merovista-DT EDTA Injection therapy. Merovista-DT EDTA Injection may interact negatively with valproic acid, an epilepsy treatment, potentially reducing its efficacy. Consequently, recent seizures might stem from this drug interaction. Alternative medications are typically prescribed in such situations.
Merovista-DT EDTA Injection has been associated with rare but reported instances of severe cutaneous reactions. Prior to commencing therapy, patients should disclose any drug or antibiotic allergies to their physician. Severe skin reactions constitute a form of allergic response; however, untreated, they pose a life-threatening risk. The appearance of a rash accompanied by fever or skin exfoliation necessitates immediate medication cessation and notification of the attending physician.
Merovista-DT EDTA Injection, a wide-ranging antibiotic, combats diverse bacterial infections. Its applications include pneumonia, complex urinary tract infections, abdominal infections, skin and soft tissue infections, bacterial meningitis, and infections arising from childbirth.
Merovista-DT EDTA Injection exhibits antibacterial activity only; it is inactive against viral and fungal pathogens. Its efficacy is demonstrated against specific bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, S. pyogenes, and S. viridans group strains. Consequently, its application should be restricted to these indicated bacterial infections.
Merovista-DT EDTA Injection has been linked in some reports to seizures. This adverse event appears more prevalent among individuals with pre-existing seizure disorders, brain damage (including wounds, ulcers, abscesses, or tumors), bacterial meningitis, or impaired renal function. Seek medical advice for a thorough assessment of your individual risk.
Your physician will determine the treatment duration. Dosage will be established based on your overall health, the specific infection, and your response to Merovista-DT EDTA Injection. Seek medical advice if you have any questions.
Merovista-DT EDTA Injection may cause mild side effects including nausea, vomiting, diarrhea, or headache. These usually subside as treatment progresses and your body adjusts. Report any bothersome side effects to your physician, who can consider alternative treatment options if necessary. Severe adverse reactions to Merovista-DT EDTA Injection are uncommon; seek immediate medical attention should they occur.
Discontinue Merovista-DT EDTA Injection only after consulting your physician. Ceasing treatment prematurely risks infection recurrence or the development of drug resistance. Similarly, inconsistent dosing, including missed or forgotten doses, can lead to the same negative outcomes. To prevent this, maintain a consistent dosing schedule. Should you miss a dose, administer it immediately and resume your regular schedule, ensuring the total daily dosage remains unchanged.
Merovista-DT EDTA Injecti...
3,662
MRP 4,249
13% off